$EGRX
EAGLE PHARMACEUTICALS, INC.

2020 Q4 Form 10-Q Financial Statement

#000082787120000028 Filed on November 02, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $49.92M $49.93M $48.26M
YoY Change 3.44% 21.34% -13.91%
Cost Of Revenue $12.54M $8.726M $11.59M
YoY Change 8.2% -28.1% -37.55%
Gross Profit $37.38M $41.20M $36.67M
YoY Change 1.94% 57.11% -2.21%
Gross Profit Margin 74.88% 82.52% 75.98%
Selling, General & Admin $18.19M $17.70M $22.46M
YoY Change -19.01% -4.53% 45.09%
% of Gross Profit 48.66% 42.95% 61.25%
Research & Development $9.400M $4.828M $11.31M
YoY Change -16.89% -52.54% 93.0%
% of Gross Profit 25.15% 11.72% 30.85%
Depreciation & Amortization $880.0K $196.0K $1.280M
YoY Change -31.25% -18.67% 52.38%
% of Gross Profit 2.35% 0.48% 3.49%
Operating Expenses $27.58M $22.53M $33.77M
YoY Change -18.33% -48.37% 58.32%
Operating Profit $9.800M $15.42M $2.897M
YoY Change 238.28% -720.65% -81.58%
Interest Expense -$390.0K $489.0K -$240.0K
YoY Change 62.5% -22.13% -52.0%
% of Operating Profit -3.98% 3.17% -8.28%
Other Income/Expense, Net $1.990M -$6.492M $700.0K
YoY Change 184.29% 11093.1%
Pretax Income $11.39M $8.925M $3.360M
YoY Change 238.99% -451.1% -77.94%
Income Tax $3.330M $1.866M $2.350M
% Of Pretax Income 29.24% 20.91% 69.94%
Net Earnings $8.060M $7.059M $1.010M
YoY Change 698.02% -395.36% -91.98%
Net Earnings / Revenue 16.15% 14.14% 2.09%
Basic Earnings Per Share $0.52 $0.08
Diluted Earnings Per Share $604.7K $0.51 $0.08
COMMON SHARES
Basic Shares Outstanding 13.03M shares 13.53M shares 13.67M shares
Diluted Shares Outstanding 13.79M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $103.2M $89.70M $109.8M
YoY Change -6.05% -23.46% 39.34%
Cash & Equivalents $103.2M $89.68M $109.8M
Short-Term Investments $0.00
Other Short-Term Assets $1.605M $3.671M $1.445M
YoY Change 11.07% 187.25% 978.36%
Inventory $8.075M $6.586M $6.566M
Prepaid Expenses
Receivables $51.12M $52.20M $48.00M
Other Receivables $0.00 $5.000M $0.00
Total Short-Term Assets $166.1M $163.8M $179.4M
YoY Change -7.46% -8.89% 9.52%
LONG-TERM ASSETS
Property, Plant & Equipment $2.077M $2.123M $2.202M
YoY Change -5.68% -8.45% -8.14%
Goodwill $39.74M $39.74M $39.74M
YoY Change 0.0% 0.0% 0.0%
Intangibles $12.92M $13.58M $15.58M
YoY Change -17.11% -16.22% -13.92%
Long-Term Investments
YoY Change
Other Assets $17.21M $13.58M $3.908M
YoY Change 340.33% 172.59% 463.11%
Total Long-Term Assets $87.13M $84.37M $75.11M
YoY Change 16.0% 9.21% 0.46%
TOTAL ASSETS
Total Short-Term Assets $166.1M $163.8M $179.4M
Total Long-Term Assets $87.13M $84.37M $75.11M
Total Assets $253.2M $248.2M $254.6M
YoY Change -0.54% -3.45% 6.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.268M $13.07M $5.462M
YoY Change 14.76% 16.35% -44.92%
Accrued Expenses $23.82M $24.45M $28.36M
YoY Change -16.02% -9.89% 20.59%
Deferred Revenue $4.966M $7.122M $8.364M
YoY Change -40.63% -31.53% 42.51%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $8.000M $8.000M $5.000M
YoY Change 60.0% 60.0% -20.0%
Total Short-Term Liabilities $38.09M $45.51M $38.82M
YoY Change -1.9% 7.45% -2.17%
LONG-TERM LIABILITIES
Long-Term Debt $25.14M $27.02M $33.56M
YoY Change -25.1% -24.29% -12.05%
Other Long-Term Liabilities $3.959M $2.844M $3.000M
YoY Change 31.97% -11.87%
Total Long-Term Liabilities $29.09M $29.86M $36.56M
YoY Change -20.41% -23.26% -4.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.09M $45.51M $38.82M
Total Long-Term Liabilities $29.09M $29.86M $36.56M
Total Liabilities $67.18M $75.37M $75.38M
YoY Change -10.88% -7.26% -3.16%
SHAREHOLDERS EQUITY
Retained Earnings $84.49M $76.43M $72.50M
YoY Change 16.54% 6.91% 24.6%
Common Stock $17.00K $17.00K $17.00K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $203.9M $199.9M $171.9M
YoY Change 18.64% 18.33% 11.67%
Treasury Stock Shares 3.682M shares 3.595M shares 2.908M shares
Shareholders Equity $186.0M $172.8M $179.2M
YoY Change
Total Liabilities & Shareholders Equity $253.2M $248.2M $254.6M
YoY Change -0.54% -3.45% 6.69%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income $8.060M $7.059M $1.010M
YoY Change 698.02% -395.36% -91.98%
Depreciation, Depletion And Amortization $880.0K $196.0K $1.280M
YoY Change -31.25% -18.67% 52.38%
Cash From Operating Activities $19.76M $5.630M -$3.200M
YoY Change -717.5% -46.99% -108.4%
INVESTING ACTIVITIES
Capital Expenditures -$170.0K -$200.0K -$130.0K
YoY Change 30.77% -35.48% 62.5%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$170.0K -$200.0K -$130.0K
YoY Change 30.77% -35.48% 62.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.120M -23.95M -4.110M
YoY Change 48.91% 1847.15% -91.85%
NET CHANGE
Cash From Operating Activities 19.76M 5.630M -3.200M
Cash From Investing Activities -170.0K -200.0K -130.0K
Cash From Financing Activities -6.120M -23.95M -4.110M
Net Change In Cash 13.47M -18.52M -7.440M
YoY Change -281.05% -303.96% -40.19%
FREE CASH FLOW
Cash From Operating Activities $19.76M $5.630M -$3.200M
Capital Expenditures -$170.0K -$200.0K -$130.0K
Free Cash Flow $19.93M $5.830M -$3.070M
YoY Change -749.19% -46.66% -108.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000827871
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2019Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2019Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36306
dei Entity Registrant Name
EntityRegistrantName
Eagle Pharmaceuticals, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8179278
dei Entity Address Address Line1
EntityAddressAddressLine1
50 Tice Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 315
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
dei City Area Code
CityAreaCode
(201)
dei Local Phone Number
LocalPhoneNumber
326-5300
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
EGRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13030130 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89681000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109775000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52199000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48004000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
6586000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
6566000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15330000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15104000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
163796000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
179449000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2123000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2202000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13584000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15583000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
39743000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
39743000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15340000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13669000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13575000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3908000 USD
CY2020Q3 us-gaap Assets
Assets
248161000 USD
CY2019Q4 us-gaap Assets
Assets
254554000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13068000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5462000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24445000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28361000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
45513000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
38823000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2844000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3000000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
27017000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33557000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
75374000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
75380000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16624681 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16537846 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
17000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
17000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
296198000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
278518000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
76432000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
72500000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
3594551 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2907687 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
199860000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
171861000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
172787000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
179174000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
248161000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
254554000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49928000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23804000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41147000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137886000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
147634000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8726000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12137000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39866000 USD
CY2020Q3 us-gaap Royalty Expense
RoyaltyExpense
3260000 USD
CY2019Q3 us-gaap Royalty Expense
RoyaltyExpense
2785000 USD
us-gaap Royalty Expense
RoyaltyExpense
9120000 USD
us-gaap Royalty Expense
RoyaltyExpense
9440000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4828000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10172000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21390000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25504000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17697000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18537000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
60411000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53906000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
34511000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
43631000 USD
us-gaap Costs And Expenses
CostsAndExpenses
114725000 USD
us-gaap Costs And Expenses
CostsAndExpenses
128716000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15417000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2484000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
23161000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
18918000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
46000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
570000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
542000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1701000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
489000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
628000 USD
us-gaap Interest Expense
InterestExpense
2164000 USD
us-gaap Interest Expense
InterestExpense
1979000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6049000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10249000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6492000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-58000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11871000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-278000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8925000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2542000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11290000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18640000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1866000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-152000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7358000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5332000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
7059000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2390000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Net Income Loss
NetIncomeLoss
3932000 USD
us-gaap Net Income Loss
NetIncomeLoss
13308000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.96
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13531372 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13668091 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13620981 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13791071 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13786803 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13668091 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13917800 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14147658 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
183964000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4722000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
42000 USD
CY2020Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
23000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
7059000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
172787000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
172481000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5651000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2390000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
175765000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
179174000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18435000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
555000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1310000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27999000 USD
us-gaap Net Income Loss
NetIncomeLoss
3932000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
172787000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
160762000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16815000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
78000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
198000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
15000000 USD
us-gaap Net Income Loss
NetIncomeLoss
13308000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
175765000 USD
us-gaap Net Income Loss
NetIncomeLoss
3932000 USD
us-gaap Net Income Loss
NetIncomeLoss
13308000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1671000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-175000 USD
us-gaap Depreciation
Depreciation
656000 USD
us-gaap Depreciation
Depreciation
725000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
980000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
754000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1999000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1890000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-7700000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18435000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
16815000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
301000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
282000 USD
egrx Fair Value Adjustment On Accelerated Share Repurchases
FairValueAdjustmentOnAcceleratedShareRepurchases
2549000 USD
egrx Fair Value Adjustment On Accelerated Share Repurchases
FairValueAdjustmentOnAcceleratedShareRepurchases
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4195000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21674000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1057000 USD
egrx Increase Decreasein Prepaid Expenseand Other Current Assets Total
IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal
2774000 USD
egrx Increase Decreasein Prepaid Expenseand Other Current Assets Total
IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal
253000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7606000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1315000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3916000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3608000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
1845000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
1813000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29737000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59187000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
17500000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
110000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
577000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
647000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18077000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-647000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
555000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
78000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1310000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
198000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
110000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
27999000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31754000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20120000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20094000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
38420000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109775000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78791000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89681000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117211000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3036000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6587000 USD
us-gaap Interest Paid Net
InterestPaidNet
1878000 USD
us-gaap Interest Paid Net
InterestPaidNet
1787000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
842000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1700000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
Interim Condensed Consolidated Financial StatementsThe accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for reporting quarterly information. Accordingly, certain information and footnote disclosures required for complete financial statements are not included herein. The condensed consolidated balance sheet at December 31, 2019 was derived from audited financial statements, but certain information and footnote disclosures normally included in the Company’s annual consolidated financial statements have been condensed or omitted. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary for the fair presentation of the financial information for the interim periods reported have been made. Results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results for the year ending December 31, 2020 or any period thereafter. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the SEC on March 2, 2020.
egrx Number Of Products Launched
NumberOfProductsLaunched
3 product
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These financial statements are presented in U.S. dollars and are prepared in accordance with U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed financial statements including disclosure of contingent assets and contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company’s critical accounting policies are those that are both most important to the Company’s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. The Company anticipates that the COVID-19 pandemic will continue to disrupt the Company’s supply chain and marketing and sales efforts for certain of its products, including Bendeka, although it is not currently expected that any disruption would be significant. As of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, assumptions and judgments or revise the carrying value of its assets or liabilities. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results may materially vary from these estimates, and any such differences may be material to the Company’s financial statements.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform with the current year presentation. None of the reclassifications were significant.</span></div>
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
86343000 USD
CY2020Q3 us-gaap Derivative Assets
DerivativeAssets
2549000 USD
CY2020Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
9800000 USD
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
98692000 USD
CY2020Q3 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
0 USD
CY2020Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
105672000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
105672000 USD
CY2019Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
0 USD
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
316000 USD
CY2019Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
556000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2204000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1673000 USD
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Receivables from our product sales have payment terms ranging from 30 to 75 days with select extended terms to wholesalers on initial purchases of product launch quantities. Our receivables from royalty revenue are due 45 days from the end of the quarter.
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
296819 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3362057 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2515599 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3130198 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2534070 shares
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7059000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2390000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3932000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13308000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13531372 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13668091 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13620981 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13791071 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
255431 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
356587 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13786803 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13668091 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13917800 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14147658 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.96
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7098000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6521000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4975000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4319000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2123000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2202000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
196000 USD
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
241000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
656000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
725000 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2439000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2460000 USD
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4096000 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3243000 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
51000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
863000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
6586000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
6566000 USD
CY2020Q3 us-gaap Prepaid Taxes
PrepaidTaxes
315000 USD
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
4661000 USD
CY2020Q3 egrx Prepaid Fda User Fee
PrepaidFDAUserFee
1682000 USD
CY2019Q4 egrx Prepaid Fda User Fee
PrepaidFDAUserFee
6345000 USD
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
440000 USD
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
191000 USD
CY2020Q3 egrx Advances To Commercial Manufacturers
AdvancesToCommercialManufacturers
4222000 USD
CY2019Q4 egrx Advances To Commercial Manufacturers
AdvancesToCommercialManufacturers
2462000 USD
CY2020Q3 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
5000000 USD
CY2019Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
0 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3671000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1445000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15330000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15104000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7122000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8364000 USD
CY2020Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6906000 USD
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6004000 USD
CY2020Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4742000 USD
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8083000 USD
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2114000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1926000 USD
CY2020Q3 egrx Accrued Researchand Development Current
AccruedResearchandDevelopmentCurrent
1123000 USD
CY2019Q4 egrx Accrued Researchand Development Current
AccruedResearchandDevelopmentCurrent
1686000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1118000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1101000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1320000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1197000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24445000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28361000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6600000 USD
egrx Number Of Operating Leases
NumberOfOperatingLeases
2 lease
egrx Number Of Operating Leases
NumberOfOperatingLeases
2 lease
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3578000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3716000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4184000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2844000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3000000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3227000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1118000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1101000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1084000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
509000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
232000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
980000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
754000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
980000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
860000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
980000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
860000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
egrx Number Of Operating Leases
NumberOfOperatingLeases
2 lease
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5903000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
641000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1362000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1376000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1291000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
820000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
413000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1941000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3962000 USD
CY2020Q1 egrx Number Of Operating Leases
NumberOfOperatingLeases
2 lease
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6607000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1345000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1362000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1376000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1291000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
820000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
413000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2506000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4101000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23100000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9516000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13584000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23100000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7517000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15583000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
667000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
630000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1999000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1890000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
665000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2622000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1369000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1570000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1898000 USD
CY2020Q3 egrx Finite Lived Intangible Assets Expected Amortization After Year Four
FiniteLivedIntangibleAssetsExpectedAmortizationAfterYearFour
5460000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13584000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2556365 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
600133 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10034 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
20890 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3125574 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3096161 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
662700 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
41951 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
185615 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3531295 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0037
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0041
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0150
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0184
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0037
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0165
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0145
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0261
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5542
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4987
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5498
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5027
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y25D
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M4D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y10D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M28D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4722000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5651000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18435000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16815000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4722000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5651000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18435000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16815000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5903000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
641000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1362000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1376000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1291000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
820000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
413000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
36000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
26000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
0 USD
CY2020Q3 us-gaap Purchase Obligation
PurchaseObligation
32944000 USD
CY2020Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
32944000 USD
CY2020Q3 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
0 USD
CY2020Q3 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
0 USD
CY2020Q3 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
0 USD
CY2020Q3 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
0 USD
CY2020Q3 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
0 USD
CY2020Q3 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
0 USD
CY2020Q3 egrx Obligations Future Payments
ObligationsFuturePayments
74847000 USD
CY2020Q3 egrx Obligations Future Payments Due Remainder Of Fiscal Year
ObligationsFuturePaymentsDueRemainderOfFiscalYear
35585000 USD
CY2020Q3 egrx Obligations Future Payments Due Year One
ObligationsFuturePaymentsDueYearOne
9362000 USD
CY2020Q3 egrx Obligations Future Payments Due In Second Year
ObligationsFuturePaymentsDueInSecondYear
27376000 USD
CY2020Q3 egrx Obligations Future Payments Due In Third Year
ObligationsFuturePaymentsDueInThirdYear
1291000 USD
CY2020Q3 egrx Obligations Future Payments Due In Fourth Year
ObligationsFuturePaymentsDueInFourthYear
820000 USD
CY2020Q3 egrx Obligations Future Payments Due In Fifth Year
ObligationsFuturePaymentsDueInFifthYear
413000 USD
CY2020Q3 egrx Obligations Future Payments Due Thereafter
ObligationsFuturePaymentsDueThereafter
0 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
276000 USD
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
286000 USD
egrx Lessee Operating Lease Number Of Contracts
LesseeOperatingLeaseNumberOfContracts
2 lease
egrx Lessee Operating Lease Number Of Contracts
LesseeOperatingLeaseNumberOfContracts
2 lease
us-gaap Operating Lease Expense
OperatingLeaseExpense
910000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
860000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5903000 USD
CY2020Q3 us-gaap Purchase Obligation
PurchaseObligation
32944000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000.0 USD
CY2020Q3 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
1000000.0 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
26000000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
36000000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1866000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-152000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7358000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7358000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5332000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5332000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.06
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.65
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.65
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
egrx Number Of Tax Jurisdictions Currently Auditing The Company
NumberOfTaxJurisdictionsCurrentlyAuditingTheCompany
3 jurisdiction
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD

Files In Submission

Name View Source Status
0000827871-20-000028-index-headers.html Edgar Link pending
0000827871-20-000028-index.html Edgar Link pending
0000827871-20-000028.txt Edgar Link pending
0000827871-20-000028-xbrl.zip Edgar Link pending
egrx-20200930.htm Edgar Link pending
egrx-20200930.xsd Edgar Link pending
egrx-20200930_cal.xml Edgar Link unprocessable
egrx-20200930_def.xml Edgar Link unprocessable
egrx-20200930_htm.xml Edgar Link completed
egrx-20200930_lab.xml Edgar Link unprocessable
egrx-20200930_pre.xml Edgar Link unprocessable
exhibit101to3q202010-q.htm Edgar Link pending
exhibit311q32020.htm Edgar Link pending
exhibit312q32020.htm Edgar Link pending
exhibit321q32020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_11.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending